US FDA removes boxed warning on LABA+ ICS combination for asthma and COPD

1029 Views

eMediNexus 22 December 2017

In an updated drug safety communication released on December 20, 2017, the US FDA has removed the Boxed Warning about asthma-related death from the drug labels of medicines that contain long-acting beta agonists (LABAs) in combination with inhaled corticosteroids (ICS).

To comment on this article,
create a free account.

Already registered?

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.